» Articles » PMID: 37021111

Oligomerization by Co-assembly of β-amyloid and α-synuclein

Overview
Specialty Biology
Date 2023 Apr 6
PMID 37021111
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant self-assembly of an intrinsically disordered protein is a pathological hallmark of protein misfolding diseases, such as Alzheimer's and Parkinson's diseases (AD and PD, respectively). In AD, the 40-42 amino acid-long extracellular peptide, β-amyloid (Aβ), self-assembles into oligomers, which eventually aggregate into fibrils. A similar self-association of the 140 amino acid-long intracellular protein, α-synuclein (αS), is responsible for the onset of PD pathology. While Aβ and αS are primarily extracellular and intracellular polypeptides, respectively, there is evidence of their colocalization and pathological overlaps of AD and PD. This evidence has raised the likelihood of synergistic, toxic protein-protein interactions between Aβ and αS. This mini review summarizes the findings of studies on Aβ-αS interactions related to enhanced oligomerization co-assembly, aiming to provide a better understanding of the complex biology behind AD and PD and common pathological mechanisms among the major neurodegenerative diseases.

Citing Articles

Single-molecule characterization of salivary protein aggregates from Parkinson's disease patients: a pilot study.

Furlepa M, Zhang Y, Lobanova E, Kahanawita L, Vivacqua G, Williams-Gray C Brain Commun. 2024; 6(3):fcae178.

PMID: 38863577 PMC: 11166177. DOI: 10.1093/braincomms/fcae178.


Rotenone Induces a Neuropathological Phenotype in Cholinergic-like Neurons Resembling Parkinson's Disease Dementia (PDD).

Giraldo-Berrio D, Mendivil-Perez M, Velez-Pardo C, Jimenez-Del-Rio M Neurotox Res. 2024; 42(3):28.

PMID: 38842585 PMC: 11156752. DOI: 10.1007/s12640-024-00705-3.

References
1.
Ren B, Zhang Y, Zhang M, Liu Y, Zhang D, Gong X . Fundamentals of cross-seeding of amyloid proteins: an introduction. J Mater Chem B. 2019; 7(46):7267-7282. DOI: 10.1039/c9tb01871a. View

2.
Paoletti F, Gaetani L, Parnetti L . The Challenge of Disease-Modifying Therapies in Parkinson's Disease: Role of CSF Biomarkers. Biomolecules. 2020; 10(2). PMC: 7072459. DOI: 10.3390/biom10020335. View

3.
Bloom G . Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014; 71(4):505-8. DOI: 10.1001/jamaneurol.2013.5847. View

4.
Atsmon-Raz Y, Miller Y . Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases. ACS Chem Neurosci. 2015; 7(1):46-55. DOI: 10.1021/acschemneuro.5b00204. View

5.
Ono K, Condron M, Teplow D . Structure-neurotoxicity relationships of amyloid beta-protein oligomers. Proc Natl Acad Sci U S A. 2009; 106(35):14745-50. PMC: 2736424. DOI: 10.1073/pnas.0905127106. View